Cipla
₹1,325.1-2.90 (-0.22%)as of 2026-10-16
- Market Cap
- ₹1,06,634Cr.
- P/E Ratio
- 29.8
- P/B Ratio
- 3.11
- EPS (TTM)
- ₹44.47
- Day Range
- ₹1,315.1 – ₹1,337.5
- Div Yield
- 0.98%
- ROCE
- 15.5%
- ROE
- 11.6%
52W Low: ₹1,16652W High: ₹1,673
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 7.0% a year over three years.
- Debt is 0.02× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Cipla — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 29.8P/E: 29.8 | P/B: 3.11Growth
ModestSales CAGR — 3Y: 7% · 1Y: 2%Profitability
ModerateROCE: 15.5% | ROE: 11.6%Key Metrics
Valuation
PEG Ratio 2.98
Price / Sales 3.76x
Price / FCF 114.9x
Book Value ₹426
Margins & returns
Operating Margin 19%
Net Margin 11.8%
Return on Assets 7.9%